Muhammad T. Mir v. Ibrar A. Nadeem

New Jersey Superior Court Appellate Division·Decided December 6, 2024·No. A-3313-23·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-3313-23

MUHAMMAD T. MIR, SALMAN RIAZ, AQSA KHAN, MT. PROSPECT PHARMACY CORP. and MUHAMMAD S. MIR,

Plaintiffs-Respondents,

v.

IBRAR A. NADEEM, BROOK PHARMACY, INC., SCOTCH PLAINS SPECIALTY PHARMACY, LLC,

Defendants/Third-Party

Plaintiffs-Appellants,

v. ABDUL NAZ,

Third-Party Defendant.

Argued November 14, 2024 – Decided December 6, 2024 Before Judges Mawla and Vinci.

On appeal from an interlocutory order of the Superior Court of New Jersey, Law Division, Essex County, Docket No. L-8411-21.

Robert A. Mintz argued the cause for appellants (McCarter & English, LLP, attorneys; Robert A. Mintz, Gregory J. Hindy and Brian W. Carroll, on the briefs).

Steven I. Adler argued the cause for respondents (Mandelbaum Barrett, PC, attorneys; Steven I. Adler and Grant Petrosyan, on the brief).

PER CURIAM We granted defendants Ibrar A. Nadeem, Brook Pharmacy, Inc. (Brook Pharmacy), and Scotch Plains Specialty Pharmacy, LLC (Scotch Plains Pharmacy) leave to appeal from the May 24, 2024 order denying their motion to disqualify the law firm of Mandelbaum Barrett PC (Mandelbaum) from representing plaintiffs Muhammad T. Mir, Salman Riaz, Aqsa Khan, Mt. Prospect Pharmacy Corp., and Muhammad S. Mir in this action. We affirm.

I.

Romana Kaleem, Esq., was a partner with the law firm Shiliwala, Janjua & Kaleem LLC (SJK) until August 2023, when she joined Mandelbaum as counsel during the pendency of this action. Prior to joining Mandelbaum, Kaleem represented Brook Pharmacy and Scotch Plains Pharmacy (collectively, the pharmacies) in certain transactional matters. Kaleem's representation of the

A-3313-23

pharmacies before she joined Mandelbaum is the basis for defendants' disqualification motion.

In October 2018, SJK entered into an engagement agreement with Brook Pharmacy to perform certain specified legal work related to the acquisition of the lease and fixtures of an existing pharmacy in Bronx, New York. The scope of work in the engagement agreement included drafting, reviewing, and negotiating a bill of sale and ancillary closing documents; reviewing a lease and lease assignment; representing the pharmacy at closing; preparing and submitting a pharmacy license application to the New York State Board of Pharmacy; drafting a shareholder agreement; drafting pharmacist and pharmacy manager employment agreements; and drafting promissory notes and security agreements. Kaleem was the SJK attorney with sole or primary responsibility for the Brook Pharmacy matter.

From 2018 through 2021, Kaleem prepared and filed numerous documents with the State of New York and the federal government indicating Nadeem was the sole owner of Brook Pharmacy. These documents included the: September 26, 2018 application for pharmacy registration to the New York Education Department, Board of Pharmacy; July 9, 2019 Medicaid enrollment application to the New York State Department of Health; March 11, 2019 Medicare

A-3313-23

enrollment application to the United States Department of Health Center for Medicare & Medicaid Services (CMS); and June 3, 2021 Medicare Part B enrollment application to CMS.

In April 2019, SJK entered into a similar engagement agreement with Scotch Plains Pharmacy to perform certain specified legal work related to the formation of the pharmacy including reviewing a lease; preparing and submitting a pharmacy license application to the New Jersey Board of Pharmacy; drafting an operating agreement; drafting pharmacist and pharmacy manager employment agreements; and drafting promissory notes and security agreements. Kaleem was the SJK attorney with sole or primary responsibility for the Scotch Plains Pharmacy matter. On May 6, 2019, Kaleem filed an application for pharmacy registration with the New Jersey Board of Pharmacy that identified Nadeem as the sole owner of Scotch Plains Pharmacy.

After the pharmacies were established, a dispute arose between Riaz, Khan, and Nadeem over their alleged ownership interests in the businesses. Nadeem contended he was the sole owner, while Riaz and Khan alleged they shared ownership with Nadeem based on a loan made in connection with the acquisition and formation of the pharmacies.

A-3313-23

On June 29, 2021, the parties entered into a settlement agreement and release (the settlement agreement) in which Riaz and Khan agreed Nadeem was the sole owner of the pharmacies. It is undisputed Kaleem did not represent any of the parties, including the pharmacies, in connection with the settlement agreement. The settlement agreement contains, as an "essential and material part of [the] [a]greement," a non-disparagement provision, which includes an acknowledgement by Riaz and Khan "that they never owned any interest in" the pharmacies.

On November 8, 2021, plaintiffs filed their initial complaint in this action alleging Nadeem breached the confidentiality provision contained in the settlement agreement. Plaintiffs asserted causes of action for breach of the settlement agreement; declaratory judgment; conspiracy; tortious interference with contract and prospective economic advantage; malicious use and abuse of process; and defamation. The pharmacies were named as defendants, but there were no direct claims for damages asserted against them. The complaint demanded a declaratory judgment that the settlement agreement is "null and void" and Riaz and Khan "continue to have majority ownership of" the pharmacies.

A-3313-23

On November 9, 2022, plaintiffs filed a second amended complaint asserting the same causes of action and seeking a declaratory judgment that the settlement agreement is "null and void" and Riaz and Khan "continue to have majority ownership interest in [the pharmacies,] (which interests they owned prior to entering into the [settlement agreement])." Plaintiffs also allege Nadeem "caused [the pharmacies] to breach the [s]ettlement [a]greement[]" and seek compensatory and punitive damages from the pharmacies for damages "as a result of the breach[] of the [s]ettlement [a]greement[] by Nadeem [and the pharmacies]." 1 On October 31, 2022, Kaleem received an email from Nadeem authorizing her to release "paperwork" regarding the pharmacies to his counsel, Robert Mintz, Esq., at the law firm McCarter & English, LLC. On January 13, 2023, Mintz wrote to Kaleem requesting the "complete file[s] with regard to [her] [prior] representation of . . . Nadeem [and the pharmacies]." Kaleem subsequently delivered the requested files to Mintz.

On July 11, 2023, Kaleem received a subpoena seeking production of documents and her deposition. By that time, Kaleem had accepted an offer of

1 Because plaintiffs allege the pharmacies breached the settlement agreement and seek damages from them as a result, their argument that the pharmacies were named only as nominal parties lacks merit.

A-3313-23

employment with Mandelbaum and was scheduled to join the firm on August 7. On August 12, in connection with her communications with Mintz regarding the subpoena, Kaleem advised him that she was "no longer at SJK and [was] practicing with [Mandelbaum]" and her new "email address [was] rkaleem@mblawfirm.com."

On January 12, 2024, defendants served a second subpoena on Kaleem seeking her deposition. Kaleem resigned from Mandelbaum around the same time. On January 30, she advised Mintz she was "no longer practicing law at Mandelbaum except on a very limited basis." 2 It is undisputed that Kaleem did not work on this matter during her employment with Mandelbaum and she did not transfer any documents relating to her representation of the pharmacies to Mandelbaum.

Free access — add to your briefcase to read the full text and ask questions with AI

Muhammad T. Mir v. Ibrar A. Nadeem, (N.J. Ct. App. 2024).

Muhammad T. Mir v. Ibrar A. Nadeem (Muhammad T. Mir v. Ibrar A. Nadeem) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

North Carolina State Bar v. Sossomon
676 S.E.2d 910 (Court of Appeals of North Carolina, 2009)
Cavallaro v. Jamco Property Mgt.
760 A.2d 353 (New Jersey Superior Court App Division, 2000)
City of Atlantic City v. Trupos
992 A.2d 762 (Supreme Court of New Jersey, 2010)
Division of Youth and Fam. Serv. v. Vj
898 A.2d 1059 (New Jersey Superior Court App Division, 2004)
Grove v. Grove Valve & Regulator Co.
213 Cal. App. 2d 646 (California Court of Appeal, 1963)
Twenty-First Century Rail Corp. v. New Jersey Transit Corp.
44 A.3d 592 (Supreme Court of New Jersey, 2012)
Dewey v. R.J. Reynolds Tobacco Co.
536 A.2d 243 (Supreme Court of New Jersey, 1988)
Zerger & Mauer LLP v. City of Greenwood
751 F.3d 928 (Eighth Circuit, 2014)
New Jersey Division of Child Protection and Permanency
149 A.3d 816 (New Jersey Superior Court App Division, 2016)
Chirino v. Proud 2 Haul, Inc.
205 A.3d 225 (New Jersey Superior Court App Division, 2017)
State ex rel. S.G.
814 A.2d 612 (Supreme Court of New Jersey, 2003)